Further evidence linking TAM signalling to the pathogenesis of MS also has emerged from studies of human MS lesions, revealing that soluble Axl and Mer proteins, which act as decoy receptors to sequester Gas6, are upregulated in chronic MS lesions, and are negatively correlated with expression of Gas6 [10]. The gene discussed is GAS6; the disease is myeloid sarcoma.